why choose us

First received: September 20, 2022

Clinical Trial: Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hepatocellular Carcinoma

Study Type: INTERVENTIONAL


Official Title: Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion: PORTAL Study

Brief Summary: This study is investigator initiated, single-institution, prospective, phase 2 open-label study to determine the efficacy and safety of combination therapy of atezolizumab/bevacizumab and proton beam therapy to portal vein tumor thrombosis with or without main primary tumor in patients with stage 3 or higher hepatocellular carcinoma (HCC) with Vp2-4 portal vein invasion who had not undergone systemic therapy for HCC.The primary endpoint of this study is progression-free survival and secondary endpoints are…

Read more